Back to search results

Advanced Cancer, Metastatic Cancer

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

JOBA | {{ defaultRegistry.registryAnchorText }} NCT02529553 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The main purpose of this study is to evaluate the safety of the study drug known as LY3076226 in participants with advanced or metastatic cancer.

Completed Study

The results of this study are not yet available.

Time Commitment

Your participation may continue for as long as you and your study doctor feel that you are benefiting from the study treatment.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


18+ years
  • Participant must have advanced or metastatic cancer
    • Part B participant must have a diagnosis of bladder cancer
    • Part B participants must have alterations of Fibroblast Growth Factor Receptor 3 (FGFR3)
  • Participant of reproductive potential must agree to use medically approved contraceptive precautions during the study and for 3 months following the last dose of study drug
  • Female participant of childbearing potential must have had a negative serum or urine pregnancy test within 7 days of the first dose of study drug and must not be breastfeeding
  • Participant must not have current acute or chronic leukemia
  • Participant must not have an active fungal, bacterial, and/or known viral infection including HIV or viral hepatitis A, B, or C

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.